The page is the record's research on the issuer — no analyst, no rating, no view. # Royalty Pharma plc (NASDAQ: RPRX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Royalty Pharma plc, listed on NASDAQ under ticker RPRX, with ISIN USG7709Q1043 and LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-X0). Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United Kingdom. Its listing status is listed, not halted. ## The disclosure read The record holds 130 filings in the twelve months from 2025-11-08 to 2026-11-08, across 77 filing days. Of these, 67 are directors' dealings, 48 are regulatory filings, 8 are results, 3 are AGM/EGM filings, 3 are corporate news, and 1 is a director change. The median gap between filing days is 3.0 days. The latest filing is dated 2026-11-06 and is of type directors_dealings, 2 days before the record date of 2026-11-08. For NASDAQ the record holds 4,359 issuers with a median cadence gap of 6.0 days, a median of 52 filings, and a median latency of 5.0 days. For the sector 2834 Pharmaceutical Preparations the record holds 526 issuers with a median cadence gap of 6.0 days, a median of 63.0 filings, and a median latency of 4.0 days. The issuer's 130 filings are above the exchange median of 52 and above the sector median of 63.0. Its cadence gap of 3.0 days is below both medians of 6.0 days. Its latency of 2 days is below the exchange median of 5.0 days and below the sector median of 4.0 days. ## Auditor The auditor of record is Ernst & Young LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, name change or segment move lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed on the record are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with an earliest sealed date of 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001802768.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/RPRX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1802768/000180276826000003/rprx-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/RPRX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/RPRX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp